CBD OIL PRODUCTION BUSINESS PLAN

I. Executive Summary

Company Description

Based in Denver, Colorado and launching in 2026, our company name evokes transparency and provenance. We operate in the premium wellness and hemp-derived CBD sector, manufacturing scientifically verified, transparently sourced CBD oil sold primarily through a direct-to-consumer e-commerce platform to a national audience of health-conscious adults. We control the full supply chain—organic U.S. hemp sourcing, in-house CO2 extraction, formulation, and third-party lab verification—and use technology to make batch-level data and certificates visible to consumers. One-liner: we deliver traceable, lab-backed CBD oil customers can trust.

Short-term goals: complete facility buildout in Q2 2026, certify organic suppliers, and achieve first-year revenue targets through targeted digital marketing and subscription launches. Long-term goals: scale capacity to serve national retail partners by 2028, expand product lines into tinctures and topicals, and maintain >60% gross margin via vertical integration and premium pricing. What sets us apart: radical transparency, in-house extraction quality control, and verifiable lab data delivered to consumers—differentiators that reduce trust friction in an unregulated market. One-liner: our economics rely on vertical control and premium positioning to sustain margins and growth.

Problem

U.S. CBD consumers face inconsistent product quality and safety due to a saturated market and uneven regulatory oversight, resulting in inaccurate cannabinoid labels, failed third-party tests, and products contaminated with heavy metals or solvents.

Health-conscious adults cannot verify origin, purity, or potency, so they spend on ineffective or risky products and cannot reliably self-manage stress, pain, anxiety, or sleep—creating a clear need for verifiable, consistently tested CBD delivered directly to consumers.

Solution

The U.S. CBD market is flooded with inconsistent, poorly labeled, and low-quality products that leave consumers unsure about purity, potency, and safety. Our solution is full seed-to-shelf control—premium U.S. hemp, CO2 extraction, and ISO 17025 third-party batch testing—so label equals content and customers get reliable, repeatable dosing. One clear promise: verified purity and potency.

We sell CBD oil tinctures, topicals, capsules, pet drops, and edibles formulated for specific use cases and verified for cannabinoid profile and absence of contaminants. Full traceability and independent lab verification solve trust and safety gaps in the market. One clear outcome: consumers can choose with confidence.

Mission Statement

Our mission is to deliver the most trusted and transparent CBD wellness solutions in the United States by controlling every step of the production journey, from cultivation to final product. We empower health-conscious individuals with pure, potent, and scientifically verified products backed by rigorous third-party testing and "seed-to-shelf" transparency. Everyone deserves access to safe, reliable, natural alternatives for wellness, and we set the standard for integrity in the hemp industry.

Key Success Factors

Core drivers that enable rapid growth, margin expansion, and customer trust.

• Seed-to-shelf transparency: batch-specific QR codes provide verifiable product history and consumer trust.
• High-margin DTC model: direct-to-consumer sales plus scalable production from 28,000 to 160,000 units annually.
• CO2 extraction facility: solvent-free, state-of-the-art processing that ensures product purity and regulatory advantage.
• Experienced management: leadership with chemistry, operations, and digital marketing expertise for consistent execution.
• Fast financial payback: breakeven in two months with strong projected EBITDA growth.

Financial Summary

Financial snapshot: the business targets strong early profitability, breakeven in Feb-2026 and rapid EBITDA growth through Year 5.

Financial requirements: maintain minimum cash of $803,000 (hit Jun-2026); initial capex ~ $650,000; total payback in 23 months; anticipated return on equity 11.36%.

Outlook: profitable from month 2 with accelerating EBITDA and a strong liquidity cushion.

Funding Requirements

Raise $803,000 to fund capital expenditures and working capital, reach breakeven in Feb-2026, and achieve full payback in 23 months.